Case Report: Transient Increase of CMR T1 Mapping Indices in a Patient With COVID-19 mRNA Vaccine Induced Acute Myocarditis.
COVID-19
T1 mapping
cardiac magnetic resonance imaging
mRNA vaccine
myocarditis
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
02
2022
accepted:
29
03
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
Acute myocarditis is commonly associated with viral infections, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Myocarditis following mRNA COVID-19 vaccination has also been reported, however this is rare and usually resolves within days or weeks. We present a case of acute myocarditis reported after vaccination with mRNA-1273 COVID-19 vaccine (Moderna) diagnosed using cardiac magnetic resonance imaging (CMR). This report describes the utility of CMR in the diagnosis and follow-up of such patients using parameters which could suggest the clinical course of myocarditis. A 23-year-old male presented in the emergency department with complaints of chest pain radiating to the left arm following vaccination with the second dose of COVID-19 mRNA-1273 vaccine (Moderna). Patient's history revealed an incidence of myocarditis in the past. CMR showed a mid-range left ventricular ejection fraction (38%) and subepicardial late gadolinium enhancement (LGE) in the inferolateral and apical myocardial segments with diffuse elevation of native T1 mapping relaxation times in all myocardial segments. The patient was admitted briefly in the intensive care unit and after a favorable clinical course was discharged from the hospital in stable condition. A follow-up CMR after 3 months revealed normalization of LVEF (57%) and native T1- times in most segments. Scarred myocardium reflecting chronic myocarditis continued to show elevated T1 times. Our patient presenting with acute myocarditis after recent COVID-19 mRNA vaccination reported a favorable clinical course. CMR revealed increased T1 mapping relaxation times diffusely spread across the myocardium and an impairment of the left ventricular function (LVEF) during the acute phase. However, the LVEF as well as the T1 times normalized at follow-up in all segments except for myocardium affected by chronic myocarditis.
Sections du résumé
Background
UNASSIGNED
Acute myocarditis is commonly associated with viral infections, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Myocarditis following mRNA COVID-19 vaccination has also been reported, however this is rare and usually resolves within days or weeks. We present a case of acute myocarditis reported after vaccination with mRNA-1273 COVID-19 vaccine (Moderna) diagnosed using cardiac magnetic resonance imaging (CMR). This report describes the utility of CMR in the diagnosis and follow-up of such patients using parameters which could suggest the clinical course of myocarditis.
Case Summary
UNASSIGNED
A 23-year-old male presented in the emergency department with complaints of chest pain radiating to the left arm following vaccination with the second dose of COVID-19 mRNA-1273 vaccine (Moderna). Patient's history revealed an incidence of myocarditis in the past. CMR showed a mid-range left ventricular ejection fraction (38%) and subepicardial late gadolinium enhancement (LGE) in the inferolateral and apical myocardial segments with diffuse elevation of native T1 mapping relaxation times in all myocardial segments. The patient was admitted briefly in the intensive care unit and after a favorable clinical course was discharged from the hospital in stable condition. A follow-up CMR after 3 months revealed normalization of LVEF (57%) and native T1- times in most segments. Scarred myocardium reflecting chronic myocarditis continued to show elevated T1 times.
Conclusions
UNASSIGNED
Our patient presenting with acute myocarditis after recent COVID-19 mRNA vaccination reported a favorable clinical course. CMR revealed increased T1 mapping relaxation times diffusely spread across the myocardium and an impairment of the left ventricular function (LVEF) during the acute phase. However, the LVEF as well as the T1 times normalized at follow-up in all segments except for myocardium affected by chronic myocarditis.
Identifiants
pubmed: 35571183
doi: 10.3389/fcvm.2022.880717
pmc: PMC9091656
doi:
Types de publication
Case Reports
Langues
eng
Pagination
880717Informations de copyright
Copyright © 2022 Ansari, Britsch, Rogowski, Duerschmied and Papavassiliu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2021 Dec 2;385(23):2132-2139
pubmed: 34614329
Pediatr Cardiol. 2022 Mar 23;:
pubmed: 35320390
Int J Cardiol. 2018 Dec 15;273:183-186
pubmed: 30236504
Circulation. 2021 Aug 10;144(6):506-508
pubmed: 34133884
J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176
pubmed: 30545455
Vaccine. 2021 Oct 8;39(42):6195-6200
pubmed: 34535317
Circ Res. 2016 Jul 8;119(2):277-99
pubmed: 27390332
Nat Rev Cardiol. 2022 Feb;19(2):75-77
pubmed: 34887571
J Cardiovasc Magn Reson. 2016 Nov 18;18(1):84
pubmed: 27855705
Eur Heart J. 2021 May 14;42(19):1866-1878
pubmed: 33596594
J Cardiol Cases. 2022 Feb 11;:
pubmed: 35169401
Rev Med Interne. 2021 Nov;42(11):797-800
pubmed: 34740463
JAMA. 2022 Jan 25;327(4):331-340
pubmed: 35076665
JACC Cardiovasc Imaging. 2013 Oct;6(10):1048-1058
pubmed: 24011774
N Engl J Med. 2021 Sep 16;385(12):1078-1090
pubmed: 34432976
Clin Imaging. 2021 Oct;78:247-249
pubmed: 34166884
Can J Cardiol. 2021 Oct;37(10):1629-1634
pubmed: 34375696